Pfizer's Weight Loss Drugs Show Promising Results in Diabetes Treatment.
TL;DR Summary
Pfizer's oral weight-loss drug, danuglipron, causes the same amount of weight loss as Novo Nordisk's injection Ozempic, according to a peer-reviewed study. The results were from a phase-two clinical trial, but the drugs were not directly compared.
- Pfizer’s weight loss drug might be the new Ozempic, study suggests NJ.com
- Pfizer's diabetes pill shows similar weight loss results as Ozempic Fox Business
- New Weight-Loss Pills Are Coming. What to Know. Barron's
- Here’s Why Pfizer (NYSE:PFE) Gained Yesterday TipRanks
- Pfizer: Solid Midstage Danuglipron Data in Diabetes and Weight Loss Supports Continued Development Morningstar
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
70%
124 → 37 words
Want the full story? Read the original article
Read on NJ.com